Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland

por Bhadhuri, Arjun, Dröschel, Daniel, Guldimann, Mike, Jetschgo, Claudia, Banhazi, Judit, Schwenkglenks, Matthias, Sutherland, C. Simone
Publicado 2022